ICON Plc (ICLR) - Financial and Strategic SWOT Analysis Review

March 2021 | 58 pages | ID: IF7C0CD6C35EN
GlobalData

Abstracts

ICON Plc (ICLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ICON plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides specialized services that span the entire lifecycle of product development. The company’s service portfolio includes adaptive trials, biosimilars, clinical research services, commercialization and outcomes, consulting, functional services provision, medical imaging, laboratory services, resourcing solutions and strategic support and tactical solutions for traditional, in vitro diagnostic and software devices. The company offers research services in areas of cancer, genomics, central nervous system, cardiovascular, endocrine and metabolic disorders, gastrointestinal, medical device, nonalcoholic steatohepatitis (NASH), ophthalmology, rare and orphan diseases, transplant and immunology, vaccines and women’s health therapeutics areas among others. ICON is headquartered in Dublin, Ireland.

ICON Plc Key Recent Developments

Feb 24,2021: Ireland’s ICON signs agreement to acquire PRA Health Sciences
Oct 21,2020: Icon reports third quarter 2020 results
Oct 19,2020: BARDA reselects ICON as preferred partner to help strengthen US emergency preparedness and response
Oct 07,2020: ICON wins best CRO at the vaccine industry excellence wwards
Sep 03,2020: ICON launches Accellacare a global clinical research network focused on increasing patient recruitment with a patient centric approach

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

ICON Plc - Key Facts
ICON Plc - Key Employees
ICON Plc - Key Employee Biographies
ICON Plc - Major Products and Services
ICON Plc - History
ICON Plc - Company Statement
ICON Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
ICON Plc - Business Description
Geographical Segment: Ireland
Performance
Geographical Segment: Other
Performance
Geographical Segment: Rest of Europe
Performance
Geographical Segment: US
Performance
ICON Plc - Corporate Strategy
ICON Plc - SWOT Analysis
SWOT Analysis - Overview
ICON Plc - Strengths
ICON Plc - Weaknesses
ICON Plc - Opportunities
ICON Plc - Threats
ICON Plc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ICON Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
ICON Plc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Oct 21, 2020: Icon reports third quarter 2020 results
Oct 19, 2020: BARDA reselects ICON as preferred partner to help strengthen US emergency preparedness and response
Oct 07, 2020: ICON wins best CRO at the vaccine industry excellence wwards
Sep 03, 2020: ICON launches Accellacare a global clinical research network focused on increasing patient recruitment with a patient centric approach
Jul 22, 2020: ICON reports second qquarter 2020 results
May 05, 2020: ICON appoints new Chief Medical Officer
Apr 22, 2020: ICON reports first quarter 2020 results
Apr 09, 2020: ICON wins multiple categories in 2020 CRO Leadership Awards third year in a row
Apr 03, 2020: ICON signs new service agreement with Pfizer
Mar 23, 2020: ICON launches the coronavirus observatory

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

ICON Plc, Key Facts
ICON Plc, Key Employees
ICON Plc, Key Employee Biographies
ICON Plc, Major Products and Services
ICON Plc, History
ICON Plc, Subsidiaries
ICON Plc, Key Competitors
ICON Plc, Ratios based on current share price
ICON Plc, Annual Ratios
ICON Plc, Annual Ratios (Cont...1)
ICON Plc, Annual Ratios (Cont...2)
ICON Plc, Interim Ratios
ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ICON Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
ICON Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

ICON Plc, Performance Chart (2016 - 2020)
ICON Plc, Ratio Charts
ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ICON Plc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021